| Recently, Vernoniacinerea (VC) has been used in smoking cessation strategy. This study aims to develop Vernoniacinerea product for students who seek the smoking cessation. So, we developed and evaluated the efficacy, safety, and satisfaction of Vernoniacinerea cookies. Objective: To evaluate efficacy of Vernoniacinereacookies for smoking cessation within 6 monthsamong current smokers, and side effect of Vernoniacinereacookies. Methods: It is a quasi-experimental study. Vernoniacinerea cookies were developed and the subjects were randomly selected into each group, 33 in VC group received 5 VC cookies per day and the other 30 are in control group. The study continued for 6 months. The subjects filled out the questionnaire paper. Baseline characteristics were evaluated by Independent t-test and Chi-square test. The primary outcome is the continuous abstinence rates (CAR) at 3 and 6 months that were evaluated relationship by Multivariable logistic regression. The Secondary outcomes are side effects and user satisfaction for Vernoniacinerea cookies. Results: The Continuous abstinence rates (CAR) at 3 and 6 months in VC group were higher than those in a control group (VC; 100%, 81.8% (p<.001), Control; 6.7%, 13.3% (p<.001)). Some minor side effects were found and subjects revealed they are satisfied in Vernoniacinerea cookies taste. Conclusion: the Continuous abstinence rates (CAR) at 3 and 6 months in VC group are significantly higher than control group (p<0.001). Subjects were satisfiedwith Vernoniacinerea cookies taste and they don’t have any severe side effects. |